Zobrazeno 1 - 10
of 100
pro vyhledávání: '"T Yu Semiglazova"'
Autor:
S A Tyulyandin, M Yu Fedyanin, T Yu Semiglazova, V M Moiseenko, S V Odintsova, B Ya Alekseev, R A Ivanov, M S Shustova
Publikováno v:
Современная онкология, Vol 19, Iss 3, Pp 5-12 (2017)
Purpose. To evaluate pharmacokinetics, pharmacodynamics, safety, immunogenicity and efficacy of intravenous infusions of BCD-100 (JSC “BIOCAD”, Russia) in increasing doses. Patients (materials) and methods. Patients with advanced malignant tumors
Externí odkaz:
https://doaj.org/article/6751069bb31a44e7bf9f32138fa3a1cd
Autor:
T Yu Semiglazova, V A Klyuge, V V Semiglazov, G M Teletaeva, P V Krivorotko, G A Dashyan, R M Paltuev, E V Tkachenko, R V Donskikh, V F Semiglazov
Publikováno v:
Современная онкология, Vol 18, Iss 2, Pp 27-33 (2016)
Since 1990-s the efficiency of treatment of patients with metastatic/advanced breast cancer (MBC) was started to evaluate not only by overall survival but also by quality of life which is characterized by physical, social, mental and emotional condit
Externí odkaz:
https://doaj.org/article/9038cd9894d74b53bb7b85786a1fe593
Autor:
T Yu Semiglazova, G A Dashyan, V V Semiglazov, A S Zhabina, M A Osipov, Z S Kotova, V V Klimenko, P V Krivorotko, V F Semiglazov
Publikováno v:
Современная онкология, Vol 17, Iss 1, Pp 19-24 (2015)
Since the 1990s, the unique data of clinical trials has been analyzed regarding the Quality of Life (QoL) Index as a one of fundamental criteria of treatment efficacy for malignant tumors and breast cancer in particular. Last decades the highest prog
Externí odkaz:
https://doaj.org/article/b6886255e8644a56bb2a2f1785466ef7
Autor:
E V Artamonova, V A Gorbunova, N V Zhukov, L V Manzjuk, A G Manihas, P M Paltuev, V F Semiglazov, T Yu Semiglazova, M B Stenina, S A Tjuljandin, V A Chubenko
Publikováno v:
Современная онкология, Vol 16, Iss 2, Pp 12-16 (2014)
The leading oncologists' meeting was held on February 7, 2014 in Moscow. Those in attendance discussed treatment approaches ofbreast cancer, and in particular, locally-advanced and metastatic breast cancer. Participants came to the conclusion that pa
Externí odkaz:
https://doaj.org/article/8d8314f2d766496e8a66aea101011950
Autor:
A. I. Stukan, S. I. Kutukova, E. A. Nefedova, V. A. Porkhanov, V. N. Bodnya, T. Yu. Semiglazova, N. A. Tsygan, V. V. Kudrina, I. I. Aseeva, Yu. Yu. Stefanova, A. A. Kurmanaliev, M. A. Chagiev
Publikováno v:
Опухоли головы и шеи, Vol 14, Iss 1, Pp 16-30 (2024)
Introduction. Chemotherapy in combination with targeted therapy (CT + TT) using a monoclonal antibody against epidermal growth factor receptor (EGFR) cetuximab and subsequent maintenance targeted therapy (CT + TT/TT) is the leading 1st line therapy o
Externí odkaz:
https://doaj.org/article/0b76fc9e06f24009ad086a171ed0dc63
Autor:
M S Motalkina, S A Kulyova, S M Alexeev, I S Zuzgin, L V Filatova, A S Zhabina, A A Zverkova, I V Ishmatova, A A Rjazankina, A S Artemyeva, T Yu Semiglazova
Publikováno v:
Современная онкология, Vol 17, Iss 2, Pp 54-56 (2015)
In our clinical example, we studied the possibility of early treatment intensification, through the use of a new combination pegfilgrastim and plerixafor as a regime of mobilization. Within 4 days (after a single injection pegfilgrastim 6 mg in D1) w
Externí odkaz:
https://doaj.org/article/6597e0dcba3e4b39b7faf3c59ad667c7
Autor:
A. I. Stukan, V. N. Bodnya, V. A. Porkhanov, T. Yu. Semiglazova, O. Yu. Chukhray, E. A. Nefedova, O. N. Nefedov, D. V. Xenodokhov, S. D. Maksimenko
Publikováno v:
Опухоли головы и шеи, Vol 13, Iss 4, Pp 101-115 (2024)
Introduction. Cigarette smoking along with alcohol consumption, infection with human papilloma (HPV) and the Epstein–Barr viruses, is one of the main risk factors for head and neck squamous cell carcinoma. It can also contribute to virus-associated
Externí odkaz:
https://doaj.org/article/1307ead25fc14680a2f8a42add62fd5f
Autor:
M L Gershanovich, T Yu Semiglazova
Publikováno v:
Современная онкология, Vol 4, Iss 4, Pp 182-185 (2002)
Основная цель работы, проведенной в НИИ онкологии им. Н.Н.Петрова, заключалась в изучении эффективности и токсического профиля нового пе
Externí odkaz:
https://doaj.org/article/2df233ea313245a79f7d6eb8c9b0c821
Autor:
A. I. Stukan, T. Yu. Semiglazova, S. I. Kutukova, V. A. Porkhanov, V. N. Bodnya, E. N. Imyanitov, V. V. Antipova, Z. K. Khachmamuk, O. Yu. Chukhray, S. D. Maksimenko
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 4, Pp 63-74 (2024)
Background. Data on the prognostic role of the PIK3CA mutation in hormone receptor-positive (HR+) HER2-negative (HER2–) breast cancer (BC) are contradictory; nevertheless, there are indications of its negative predictive and prognostic significance
Externí odkaz:
https://doaj.org/article/88640b6bad6447928620a2997b883c2b
Autor:
V. M. Merabishvili, V. F. Semiglazov, A. V. Komiakhov, T. Yu. Semiglazova, P. V. Krivorotko, А. M. Belyaev
Publikováno v:
Опухоли женской репродуктивной системы, Vol 19, Iss 3, Pp 16-24 (2023)
Background. Breast cancer is the main cause of morbidity and mortality of the female population among economically developed countries, including in Russia. Despite the continued increase in morbidity, mortality is decreasing, which is confirmed by a
Externí odkaz:
https://doaj.org/article/026f70f8695d4c6f9f85d908899efae1